VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Hood, John D ^a   Meininger, Cynthia J ^a   Ziche, Marina ^b   Granger, Harris J ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Endothelial cell; Human umbilical vein endothelial cells; Nitric oxide; Nitric oxide synthase; Vascular endothelial growth factor

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0031943236     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.3.h1054     Document Type: Article

References (23)

1. Arnal, J. F., J. Yamin, S. Dockery, and D. G. Harrison. Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am. J. Physiol. 267 (Cell Physiol. 36): C1381-C1388, 1994.
2. Bates, D. O., and F. E. Curry. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H2520-H2528, 1996.
3. 2+ and von Willebrand factor release in human endothelial cells. Am. J. Pathol. 138: 213-221, 1991.
4. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
5. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1: 27-31, 1995.
6. Harrison, D. G., R. C. Venema, J. F. Arnal, N. Inoue, Y. Ohara, H. Sayegh, and T. J. Murphy. The endothelial cell nitric oxide synthase: is it really constitutively expressed? Agents Actions Suppl. 45: 107-117, 1995.
7. Inoue, N., R. C. Venema, H. S. Sayegh, Y. Ohara, T. J. Murphy, and D. G. Harrison. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-betal. Arterioscler. Thromb. Vasc. Biol. 15: 1255-1261, 1995.
8. Janssens, S. P., A. Shimouchi, T. Quertermous, D. B. Bloch, and K. D. Bloch. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J. Biol. Chem. 267: 14519-14522, 1992.
9. Ku, D. D., J. K. Zaleski, S. Liu, and T. A. Brock. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265 (Heart Circ. Physiol. 34): H586-H592, 1993.
10. Liao, J. K., J. J. Zulueta, F. S. Yu, H. B. Peng, C. G. Cote, and P. M. Hassoun. Regulation of bovine endothelial constitutive nitric oxide synthase by oxygen. J. Clin. Invest. 96: 2661-2666, 1995.
11. Myers, P. R., R. Guerra, Jr., and D. G. Harrison. Release of NO and EDRF from cultured bovine aortic endothelial cells. Am. J. Physiol. 256 (Heart Circ. Physiol. 25): H1030-H1037, 1989.
12. Myers, P. R., R. L. Minor, R. Guerra, Jr., J. N. Bates, and D. G. Harrison. The vasorelaxant properties of the endothelium-derived relaxing factor more closely resembles S-nitrocysteine than nitric oxide. Nature 345: 161-163.
13. Morbidelli, L., C.-H. Chang, J. G. Douglas, H. J. Granger, F. Ledda, and M. Ziehe. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol. 270 (Heart Circ. Physiol. 39): H411-H415, 1996.
14. Rakusan, K. Coronary angiogenesis. From morphometry to molecular biology and back. Ann. NY Acad. Sci. 752: 257-266, 1995.
15. Shweiki, D., A. Itin, D. Soffer, and E. Keshet. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845, 1992.
16. Thomas, K. A. Vascular endothelial growth factor, a potent and selective angiogenic agent. J. Biol. Chem. 271: 603-606, 1996.
17. Uematsu, M., Y. Ohara, J. P. Navas, K. Nishida, T. J. Murphy, R. W. Alexander, R. M. Nerem, and D. G. Harrison. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am. J. Physiol. 269 (Cell Physiol. 38): C1371-C1378, 1995.
18. Wu, H. M., Q. Huang, Y. Yuan, and H. J. Granger. VEGF induces NO-dependent hyperpermeability in coronary venules. Am. J. Physiol. 271 (Heart Circ. Physiol. 40): H2735-H2739, 1996.
19. Yang, R. H., S. Bunting, A. Ko, B. Keyt, N. Ferrara, and H. Jin. Intravenous infusion of vascular endothelial growth factor (VEGF) substantially attenuates its hemodynamic effects (Abstract). FASEB J. 11: A500, 1997.
20. Yang, R., R. Thomas, S. Bunting, A. Ko, N. Ferrara, B. Keyt, J. Ross, and H. Jin. Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J. Cardiovasc. Pharmacol. 27: 838-844, 1996.
21. Yuan, Y., H. J. Granger, D. C. Zawieja, D. V. DeFily, and W. M. Chilian. Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade. Am. J. Physiol. 264 (Heart Circ. Physiol. 33): H1734-H1739, 1993.
22. Ziehe, M., L. Morbidelli, E. Masini, H. Granger, P. Geppetti, and F. Ledda. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem. Biophys. Res. Commun. 192: 1198-1203, 1993.
23. Ziehe, M., A. Parenti, F. Ledda, P. Dell'Era, H. J. Granger, C. A. Maggi, and M. Presta. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ. Res. 80: 845-852, 1997.